Paraneoplastic neurological degenerations: keys to tumour immunity
- 1 January 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 4 (1), 36-44
- https://doi.org/10.1038/nrc1255
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapyProstate Cancer and Prostatic Diseases, 2004
- Nova Regulates GABAA Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing EnhancerMolecular and Cellular Biology, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- HuR and mRNA stabilityCellular and Molecular Life Sciences, 2001
- Normalization of the Tumor Marker CA-125 after Oophorectomy in a Patient with Paraneoplastic Cerebellar Degeneration without Detectable CancerGynecologic Oncology, 1997
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996
- Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor systemNeuron, 1993
- Gynecologic Cancer in Patients With Subacute Cerebellar Degeneration Predicted by Anti-Purkinje Cell Antibodies and Limited in Metastatic VolumeMayo Clinic Proceedings, 1990
- Selective Expression of Purkinje-Cell Antigens in Tumor Tissue from Patients with Paraneoplastic Cerebellar DegenerationNew England Journal of Medicine, 1990
- IMMUNOFLUORESCENT DETECTION OF ANTIBODIES AGAINST NEURONES IN SENSORY CARCINOMATOUS NEUROPATHYBrain, 1965